J Stroke.
2013 Sep;15(3):144-152.
Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation
- Affiliations
-
- 1Department of Neurology, and Clinical Research Center for Stroke, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea. bwyoon@snu.ac.kr
Abstract
- Stroke associated with non-valvular atrial fibrillation (NVAF) is one of the most important subtypes of ischemic stroke, and its importance is becoming even more apparent in an aging population. To assess the risk of stroke associated with NVAF, the CHADS2 and CHA2DS2-VASc scores are mainly used. Such scores can be used to predict the recurrence and prognosis of ischemic stroke. In addition, new oral anticoagulants (NOACs) and devices are being evaluated in the prevention of stroke associated with NVAF in addition to treatment with the conventional oral anticoagulant, warfarin. Since clinical experience with NOACs is not globally sufficient, a cautious approach is needed.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
- The Primary Goal of Anticoagulation in Atrial Fibrillation to Prevent Stroke and Not to Offer the Apparently Cheapest Treatment
- Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
- Anticoagulation in Atrial Fibrillation
- Cardioembolic Stroke in Atrial Fibrillation-Rationale for Preventive Closure of the Left Atrial Appendage
